Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Complete Response
.
Show all posts
Showing posts with label
Complete Response
.
Show all posts
Monday, August 3, 2026
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
›
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies desi...
Friday, August 9, 2024
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
›
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has provided a Complete Response resubmissio...
›
Home
View web version
